-
公开(公告)号:US20220169808A1
公开(公告)日:2022-06-02
申请号:US17537728
申请日:2021-11-30
发明人: Wei-Hong CHANG , Ching-Mei CHEN , Grace H. CHEN , Hsin-Hsin SHEN , Yuchi WANG , Ming-Chia YANG , Li-Hsin LIN , Sen-Lu CHEN , Yi-Hsuan LEE , Jian-Wei LIN , Liang-Cheng SU
摘要: An anti-curling film is provided. The anti-curling film includes a first portion and a second portion covering the first portion. The first portion includes polylactic acid (PLA), polycaprolactone (PCL), polyethylene glycol dimethacrylate (PEGDMA) and a photoinitiator. The second portion includes polycaprolactone (PCL), gelatin, hyaluronic acid (HA), alginate (AA), polyvinyl alcohol (PVA) or a combination thereof.
-
公开(公告)号:US20210269765A1
公开(公告)日:2021-09-02
申请号:US17126942
申请日:2020-12-18
发明人: Chia-Jung LU , Jing-En HUANG , Liang-Cheng SU , Hsin-Hsin SHEN , Yuchi WANG , Ying-Hsueh CHAO , Li-Hsin LIN , Hsiu-Hua HUANG
摘要: A temperature-sensitive cell culture composition is provided. The temperature-sensitive cell culture composition includes a hydrogel, a cellulose, a gelatin and a collagen. Based on 1 part by weight of the collagen, a content of the hydrogel is between 0.03 parts by weight and 60 parts by weight, a content of the cellulose is between 150 parts by weight and 360 parts by weight, and a content of the gelatin is between 21 parts by weight and 12 parts by weight. In addition, a method for using the temperature-sensitive cell culture composition, a method for forming the temperature-sensitive cell culture composition, and a use of the temperature-sensitive cell culture composition are also provided.
-
公开(公告)号:US20210196648A1
公开(公告)日:2021-07-01
申请号:US16731979
申请日:2019-12-31
发明人: Hsin-Hsin SHEN , Yuchi WANG , Li-Hsin LIN , Ming-Chia YANG , Hsiu-Hua HUANG , Liang-Cheng SU , Ying-Hsueh CHAO , Jing-En HUANG
IPC分类号: A61K9/70
摘要: A drug-containing multilayer film provided. The drug-containing multilayer film includes: a drug-containing layer; and an anti-adhesion layer on a surface of the drug-containing layer. The drug-containing layer is composed of a first composition including a first polymer material and a drug, and the first polymer material includes at least one selected from the group consisting of: polylactic acid (PLA) and polyethylene glycol (PEG), and the weight ratio of the first polymer material to the drug is about 1:0.01-0.3. The anti-adhesion layer is composed of a second composition, and the second composition includes a second polymer material, and the second polymer material includes at least one selected from the group consisting of polylactic acid and polyethylene glycol.
-
-